Company intelligence / Profile preview

Gilvasan Pharma GmbH

Vienna, Vienna, Austriagilvasan.at ↗

Ownership: Private
Development stage: Commercial

Overview

Gilvasan Pharma specializes in the distribution of pharmaceuticals in hospitals with a focus on heparin products. They produce heparins in Austria and have been supplying partners in hospitals and private practices for more than a decade with consistently high quality products[1].

Modalities: Small molecules (specifically heparin products)
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

heparin sodium

Commercial

Indications: Anticoagulation

Partnerships

Macure Pharma (Danish company) - Gilvasan has been responsible for the distribution of Macure Pharma's products in Austria since 2021[1]

Beyond the preview

Go deeper on Gilvasan Pharma GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gilvasan Pharma GmbH.

Explore the full profile